Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 42
Filter
Add more filters









Publication year range
1.
FDA approves Galafold, a triumph for Amicus.
Moran, Nuala.
Nat Biotechnol ; 36(10): 913, 2018 10 11.
Article in English | MEDLINE | ID: mdl-30307912

Subject(s)
1-Deoxynojirimycin/analogs & derivatives , Fabry Disease/drug therapy , 1-Deoxynojirimycin/therapeutic use , Biotechnology , Drug Approval , Fabry Disease/enzymology , Fabry Disease/genetics , Humans , United States , United States Food and Drug Administration
2.
Biotech startups woo increasing numbers of crowdfunders.
Moran, Nuala.
Nat Biotechnol ; 35(4): 299-300, 2017 Apr 11.
Article in English | MEDLINE | ID: mdl-28398308
3.
From the bottom of a DNA cocktail glass.
Moran, Nuala.
Nat Biotechnol ; 31(10): 868, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24104742

Subject(s)
DNA/genetics , Biotechnology/economics , Europe , Plants, Genetically Modified
4.
Biotechs to tap into Horizon 2020's $93 billion.
Moran, Nuala.
Nat Biotechnol ; 31(9): 779, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24022145

Subject(s)
Biotechnology/economics , Drug Industry/economics , Europe
5.
Court injunction threatens clinical data transparency push.
Moran, Nuala.
Nat Biotechnol ; 31(7): 581-2, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23839133

Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Drug Approval , Adalimumab , European Union , Humans
6.
AstraZeneca juggernaut heads for Cambridge.
Moran, Nuala.
Nat Biotechnol ; 31(6): 476-8, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23752416

Subject(s)
Drug Industry/economics , Research/economics , Drug Industry/trends , Humans , Research/trends , Small Molecule Libraries/economics , United Kingdom
7.
No-fee university licenses spur biotech partnerships.
Moran, Nuala.
Nat Biotechnol ; 31(5): 376, 2013 May.
Article in English | MEDLINE | ID: mdl-23657381

Subject(s)
Biotechnology/organization & administration , Intellectual Property , Interinstitutional Relations , Licensure , Ownership , Public-Private Sector Partnerships/organization & administration , Universities/organization & administration , Manitoba
8.
Mouse platforms jostle for slice of humanized antibody market.
Moran, Nuala.
Nat Biotechnol ; 31(4): 267-8, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23563400

Subject(s)
Antibodies, Monoclonal, Humanized/economics , Marketing/economics , Animals , Antibodies, Monoclonal, Humanized/therapeutic use , Drug Industry/economics , Drug Industry/legislation & jurisprudence , Genetic Engineering/economics , Humans , Intellectual Property , Marketing/legislation & jurisprudence , Mice , Mice, Transgenic
9.
Wyss Institute to rise in Merck Serono shell.
Moran, Nuala.
Nat Biotechnol ; 31(3): 188, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23471058

Subject(s)
Biotechnology/organization & administration , Drug Industry/organization & administration , Biotechnology/economics , Drug Industry/economics , Germany , Humans , Switzerland
10.
Startups, inventors cheer European unified patent.
Moran, Nuala.
Nat Biotechnol ; 31(2): 92-3, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23392490

Subject(s)
Drug Industry/economics , Inventors/economics , Patents as Topic , Europe , Humans
11.
Brüstle patent holds up in Germany.
Moran, Nuala.
Nat Biotechnol ; 31(2): 94, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23392495

Subject(s)
Stem Cell Research , Germany , Humans , Patents as Topic , Stem Cell Research/ethics , Stem Cell Research/legislation & jurisprudence
12.
Big players jostle for pole position in muscular dystrophy.
Moran, Nuala.
Nat Biotechnol ; 30(10): 904-5, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23051793

Subject(s)
Muscular Dystrophies/drug therapy , Animals , Antibodies/therapeutic use , Clinical Trials as Topic , Exons/genetics , Follistatin/therapeutic use , Genetic Therapy , Humans , Mice , Muscle Development , Muscular Dystrophies/economics , Small Molecule Libraries/therapeutic use
13.
First gene therapy nears landmark European market authorization.
Moran, Nuala.
Nat Biotechnol ; 30(9): 807-9, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22965030

Subject(s)
Genetic Therapy/history , Genetic Therapy/trends , Europe , Genetic Vectors/therapeutic use , History, 20th Century , History, 21st Century , Humans , Hyperlipoproteinemia Type I/therapy
14.
Swiss hope for phoenix from Merck Serono's ashes.
Moran, Nuala.
Nat Biotechnol ; 30(7): 569-70, 2012 Jul 10.
Article in English | MEDLINE | ID: mdl-22781660

Subject(s)
Drug Industry/economics , Humans , Switzerland
15.
Agency defies advice and rejects gene therapy for third time.
Moran, Nuala.
Nat Biotechnol ; 30(6): 474, 2012 Jun 07.
Article in English | MEDLINE | ID: mdl-22678366

Subject(s)
Drug Approval/legislation & jurisprudence , Genetic Therapy/legislation & jurisprudence , Hyperlipoproteinemia Type I/therapy , European Union , Humans
16.
Affymax poised to challenge Amgen.
Moran, Nuala.
Nat Biotechnol ; 30(5): 377-9, 2012 May 07.
Article in English | MEDLINE | ID: mdl-22565946

Subject(s)
Anemia/drug therapy , Biotechnology/trends , Erythropoietin/therapeutic use , Biotechnology/methods , Commerce , Epoetin Alfa , Erythropoiesis/physiology , Erythropoietin/chemistry , Humans , Patents as Topic , Peptides/pharmacology , Recombinant Proteins/chemistry , United States
17.
Biotech innovators jump on biosimilars bandwagon.
Moran, Nuala.
Nat Biotechnol ; 30(4): 297-9, 2012 Apr 10.
Article in English | MEDLINE | ID: mdl-22491261

Subject(s)
Biosimilar Pharmaceuticals/economics , Drug Industry/economics , Europe , Humans , United States , United States Food and Drug Administration
18.
UK government unveils innovation booster.
Moran, Nuala.
Nat Biotechnol ; 30(2): 125, 2012 Feb 08.
Article in English | MEDLINE | ID: mdl-22318020

Subject(s)
Industry/economics , Research/economics , Small Business/economics , Universities/economics , Biological Science Disciplines/economics , Government , Humans , Tax Exemption/economics , United Kingdom
19.
Incyte comes of age with JAK inhibitor approval.
Moran, Nuala.
Nat Biotechnol ; 30(1): 3-5, 2012 Jan 09.
Article in English | MEDLINE | ID: mdl-22231071

Subject(s)
Janus Kinase 1/antagonists & inhibitors , Janus Kinase 2/antagonists & inhibitors , Primary Myelofibrosis/drug therapy , Pyrazoles/therapeutic use , Benzamides/therapeutic use , Clinical Trials as Topic , Drug Approval , Drug Industry , Humans , Nitriles , Pyrimidines/therapeutic use , United States , United States Food and Drug Administration
20.
European court bans embryonic stem cell patents.
Moran, Nuala.
Nat Biotechnol ; 29(12): 1057-9, 2011 Dec 08.
Article in English | MEDLINE | ID: mdl-22158341

Subject(s)
Embryo Research/legislation & jurisprudence , Embryonic Stem Cells , Patents as Topic/legislation & jurisprudence , Embryo Research/ethics , Europe , Humans , Judicial Role
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL